NewAmsterdam Pharma Company N.V. (NAMSW) has 14 已知的内部人和机构持有人记录. 最大持有人为 ForGrowth NAP B.V. 持有 11,831,461 股. 其他重要持有人包括 Bain Capital Life Sciences Investors, LLC 和 Topper James N.
过去12个月，内部人进行了 39 笔交易，涉及 NAMSW 股票 — 12 笔买入 (价值为 $12.95M) 和 25 笔卖出 (价值为 $39.65M). 内部人卖出超过买入.
NAMSW 內部人持股
最大持股人
ForGrowth NAP B.V.
11,831,461 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Forgrowth Nap B.v. |
10 Percent Owner |
11,831,461 |
2024-01-02 |
|
| 2 |
Bain Capital Life Sciences Investors, Llc |
10 Percent Owner |
10,473,913 |
2023-12-29 |
|
| 3 |
Topper James N |
Director |
3,028,524 |
2025-09-17 |
|
| 4 |
Kling Douglas F |
Chief Operating Officer |
323,771 |
2024-01-03 |
|
| 5 |
Davidson Michael H. |
Chief Executive Officer |
174,144 |
2026-03-02 |
|
| 6 |
Kastelein Johannes Jacob Pieter |
Chief Scientific Officer |
69,302 |
2026-03-09 |
|
| 7 |
Somaiya Mayur Ian |
Chief Financial Officer |
58,382 |
2026-01-22 |
|
| 8 |
Kooij Louise Frederika |
Chief Accounting Officer |
24,353 |
2026-01-29 |
|
| 9 |
Gulfo Adele M. |
Director |
14,260 |
2026-01-09 |
|
| 10 |
Mckenna Mark C. |
Director |
10,360 |
2026-01-09 |
|
| 11 |
Lewis William |
Director |
10,360 |
2026-01-09 |
|
| 12 |
Van Der Kamp Hilde Johanna |
Director |
10,360 |
2026-01-09 |
|
| 13 |
Smither John W |
Director |
10,360 |
2026-01-09 |
|
| 14 |
Lange Louis G |
Director |
10,360 |
2026-03-12 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-11 |
Lange Louis G |
Director |
知情卖出 |
446 |
$31.23 |
$13.93K |
| 2026-03-09 |
Lange Louis G |
Director |
实值期权行权 |
44,619 |
$11.50 |
$513.12K |
| 2026-03-06 |
Lange Louis G |
Director |
知情卖出 |
28,186 |
$29.41 |
$828.95K |
| 2026-03-09 |
Kastelein Johannes Jacob Pieter |
Chief Scientific Officer |
知情卖出 |
101,409 |
$30.29 |
$3.07M |
| 2026-03-06 |
Kastelein Johannes Jacob Pieter |
Chief Scientific Officer |
知情卖出 |
94,124 |
$30.32 |
$2.85M |
| 2026-03-05 |
Kastelein Johannes Jacob Pieter |
Chief Scientific Officer |
知情卖出 |
104,467 |
$30.30 |
$3.17M |
| 2026-03-02 |
Davidson Michael H. |
Chief Executive Officer |
知情卖出 |
443,707 |
$33.25 |
$14.75M |
| 2026-02-26 |
Davidson Michael H. |
Chief Executive Officer |
知情卖出 |
17,924 |
$34.44 |
$617.3K |
| 2026-02-25 |
Davidson Michael H. |
Chief Executive Officer |
知情卖出 |
1,300 |
$36.68 |
$47.68K |
| 2026-02-24 |
Davidson Michael H. |
Chief Executive Officer |
知情卖出 |
3,161 |
$36.46 |
$115.25K |
| 2026-02-20 |
Kastelein Johannes Jacob Pieter |
Chief Scientific Officer |
知情卖出 |
30,789 |
$35.46 |
$1.09M |
| 2026-01-28 |
Kooij Louise Frederika |
Chief Accounting Officer |
知情卖出 |
32,612 |
$31.80 |
$1.04M |
| 2026-01-27 |
Kooij Louise Frederika |
Chief Accounting Officer |
知情卖出 |
39,816 |
$32.62 |
$1.3M |
| 2026-01-26 |
Kooij Louise Frederika |
Chief Accounting Officer |
知情卖出 |
309 |
$33.45 |
$10.34K |
| 2026-01-23 |
Kooij Louise Frederika |
Chief Accounting Officer |
知情卖出 |
12,767 |
$34.37 |
$438.8K |
| 2026-01-21 |
Somaiya Mayur Ian |
Chief Financial Officer |
知情卖出 |
24,362 |
$33.80 |
$823.44K |
| 2026-01-20 |
Somaiya Mayur Ian |
Chief Financial Officer |
知情卖出 |
19,604 |
$32.38 |
$634.78K |
| 2026-01-07 |
Van Der Kamp Hilde Johanna |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Mckenna Mark C. |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Gulfo Adele M. |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Davidson Michael H. |
Chief Executive Officer |
限制性股票授予 (RSU) |
364,000 |
$35.45 |
$12.9M |
| 2026-01-07 |
Smither John W |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Lewis William |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Lange Louis G |
Director |
限制性股票授予 (RSU) |
3,400 |
- |
- |
| 2026-01-07 |
Kooij Louise Frederika |
Chief Accounting Officer |
限制性股票授予 (RSU) |
12,000 |
- |
- |
